Paper Review Records
All Paper Review Records
10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
232
days
Inavolisib: a second-generation PI3Kα inhibitor in HR+/HER2-negative breast cancer
AuthorsElaria Abdy; Jean-Pierre Betancourt; Supratik Kar
Affiliations1. Kean University
152
days
Drug-drug interactions in patients living with HIV and major depression
AuthorsIvy Antwi; Theodore J. Cory
Affiliations1. University of Tennessee Health Science Center
95
days
An update on beta-lactam–beta-lactamase inhibitor combinations for the treatment of carbapenem-resistant Gram-negative pathogens
AuthorsIlias Karaiskos; Aikaterini Gkoufa; Evdoxia Kyriazopoulou; Eleni Polyzou; Vasiliki Rapti; Konstantinos Ioannidis; Evangelia Chrysanthopoulou; Zoe Athanassa; Karolina Akinosoglou; Garyphalia Poulakou; On behalf of the Study Group of the Hellenic Group for the Combat of Antimicrobial Resistance in Critically Ill Patients of the Hellenic Society of Chemotherapy
Affiliations1. Hygeia General Hospital; 2. National and Kapodistrian University of Athens, Laikon General Hospital; 3. Attikon General University Hospital, Medical School, National and Kapodistrian University of Athens; 4. University of Patras; 5. University General Hospital of Patras; 6. National & Kapodistrian University of Athens; 7. Sismanogleio General Hospital
96
days
The use of natural language processing in predictive toxicology
AuthorsThomas Hartung
Affiliations1. Johns Hopkins University Bloomberg School of Public Health
85
days
Effect of concomitant rifampin and clarithromycin on elexacaftor-tezacaftor-ivacaftor using a physiologically based pharmacokinetic (PBPK) modeling approach
AuthorsMadeline Sanders; Eunjin Hong; Manya Jain; Paul Beringer
Affiliations1. University of Southern California; 2. Dongguk University-Seoul; 3. USC Anton Yelchin CF Clinic, Keck Medicine of USC
119
days
Optimizing tamoxifen therapy in breast cancer: a narrative review of dose escalation in patients with CYP2D6 polymorphisms
AuthorsJuliana Henrique Duarte; Jose Claudio Casali-da-Rocha; Rafael Linden; Marina Venzon Antunes
Affiliations1. Feevale University; 2. AC Camargo Cancer Center
521
days
Sex differences and impact of age-based menopausal status on tacrolimus pharmacokinetics: results of the TransplantLines Biobank and Cohort study
AuthorsTanja R. Zijp; Svea Nolte; Tim J. Knobbe; Vincent E. de Meijer; C. Tji Gan; Stephan J.L. Bakker; Iris E. Sommer; Sieta T. de Vries; Daan J. Touw; On behalf of TransplantLines investigators
Affiliations1. University of Groningen, University Medical Center Groningen; 2. University of Groningen
180
days
Gastrointestinal bleeding risk among antithrombotics users: a propensity score matched study of drug classes
AuthorsPrajwal M. Pradhan; Erich Kummerfeld; Steven Johnson; Gyorgy Simon; Terrence Adam
Affiliations1. University of Minnesota; 2. Sioux Falls Veterans Administration
88
days
Evaluation of the pharmacokinetics of emerging therapeutics for high grade glioma
AuthorsAntonio Ruggiero
Affiliations1. Fondazione Policlinico Universitario Agostino Gemelli IRCCS; 2. Università Cattolica del Sacro Cuore
105
days
Complex in vitro model developers’ perspective on advanced hepatic in vitro culture methods for predictive drug safety
AuthorsMaria Vittoria Colombo; Anna Borgström; Bruno Guy Henri Filippi
Affiliations1. InSphero AG
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days